In-Stock vs Made-to-Order Retatrutide: Cost per mg Check
In-stock means an existing lot ships; made-to-order starts a run after you order. Catalog, Sep 2026: $100/10 mg is $10.00/mg; $195/20 mg is $9.75/mg.
- retatrutide
- vendor-listings
- sourcing
- pricing
On a retatrutide vendor listing, an in-stock note means a finished lot already sits in the vendor’s inventory and your order ships against that lot. A made-to-order note means the fill, and sometimes the synthesis, starts after your order clears, so the lot number, the certificate of analysis, and the ship date all get assigned later. The difference usually does not show up in the price. It shows up in which lot you receive paperwork for, and in how much of the delivery timeline the vendor controls.
What does an in-stock note commit the vendor to?
An in-stock note commits the vendor to shipping material that has already been produced, tested, and labeled. The vendor is holding units and carrying their storage cost, which is why in-stock listings normally cap order quantity at whatever remains rather than setting a floor.
The documentation trail is also closed before you order. A vendor selling from held stock can name the lot and post that lot’s certificate of analysis on the page, because both existed before the listing went live. A page that carries an in-stock note and no lot identifier is making a claim about availability only, not about documentation. Between the two states sits the backorder case, where the listing’s restock timing note is describing a run that has already started somewhere upstream.
Does made-to-order change what you pay per mg?
Not on its own. Cost per mg is set by the vial format, and made-to-order listings often carry a different set of formats than the ones a vendor keeps on the shelf. Run the arithmetic before accepting a format substitution.
| Vial format | Catalog price (USD) | Arithmetic | Cost per mg (USD) |
|---|---|---|---|
| 10 mg | 100 | 100 ÷ 10 | 10.00 |
| 20 mg | 195 | 195 ÷ 20 | 9.75 |
| 2 × 10 mg | 200 | (100 × 2) ÷ 20 | 10.00 |
Cost per mg by retatrutide vial format, computed from list prices as of September 2026 from the HEEZ catalog. The third column shows the division used; no figure here comes from anywhere else.
Two 10 mg vials and one 20 mg vial both hold 20 mg of material, but the two-vial route costs $200 against $195, a $5 gap that works out to $0.25/mg (10.00 − 9.75), or 0.25 ÷ 10.00 = 2.5% cheaper per mg on the single larger vial, prices as of September 2026 from the HEEZ catalog. So when a made-to-order note lands on the 20 mg format and the 10 mg format stays in stock, the substitution on offer is the more expensive one per mg, and the vendor is not obliged to point that out.
Why do retatrutide listings carry made-to-order notes so often?
There is no approved commercial product behind this compound to generate steady inventory. The manufacturer’s pre-approval expanded access record for retatrutide covers single-patient access for adults with a body mass index of at least 35 kg/m² and at least two serious or life-threatening obesity-related complications who cannot enter an ongoing trial, which is the pathway used while a molecule is still investigational. Nothing on that pathway produces catalog stock. Research-use material is made in discrete runs, and a run that is not yet sold is capital sitting in a freezer.
Vial formats trace back to the published dose arms. The phase 2 obesity trial reported in the New England Journal of Medicine in 2023 randomized 338 adults to once-weekly subcutaneous retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg, or placebo, for 48 weeks, with a primary endpoint of percentage body-weight change at 24 weeks: −17.5% in the 12 mg group against −1.6% with placebo. A catalog holding 10 mg and 20 mg vials is bracketing that published range rather than matching any single arm, which is part of why the smaller format turns over faster and the larger one lands in made-to-order status more often. Both formats are research material sold for laboratory use only.
Which listing fields change between the two notes?
| Listing field | In-stock listing | Made-to-order listing |
|---|---|---|
| Lot number | Assigned, and often printed on the page | Not assigned until the run completes |
| Certificate of analysis | Posted for the lot on hand | Issued after fill, sometimes sent post-shipment |
| Ship window | Quoted in business days | Quoted as production lead time plus shipping |
| Price | Fixed at the figure shown | May be re-quoted if run input costs moved |
| Quantity control | Ceiling set by units remaining | Floor set by minimum run size |
| Cancellation | Usually allowed before dispatch | Often closed once the run starts |
Structural comparison of how the same six listing fields read under each note. This table contains no figures, so nothing in it derives from a source.
The price row is the one that catches people. A made-to-order page shows a price because the storefront needs one, not because the vendor has committed to it for a run that has not been costed yet. If the figure on a made-to-order page has not moved in months while the format has been unavailable the whole time, you are looking at a placeholder, which is one of the markers of a listing that has gone stale.
How do you tell which note a listing is really carrying?
Vendors use the two phrases loosely, and some use neither. Six checks settle it from the page itself:
- Look for a lot identifier. A named lot means the material exists. No lot identifier anywhere on the page or in the COA link means nothing has been filled yet.
- Compare the COA date to the listing date. A certificate dated before the listing’s last revision describes stock on hand. A page promising a certificate “with your order” describes a run.
- Read the ship wording, not the badge. A window quoted in business days is inventory. A window quoted in weeks, or expressed as a lead time, is production.
- Check whether every format shares one lead time. Uniform lead times across all vial sizes point to made-to-order, because real inventory depletes at different rates per format.
- Test the cart. Add more units than a small vendor would plausibly hold. An in-stock page will stop you at its remaining count; a made-to-order page will take the number.
- Check the quantity control at the other end. An in-stock listing sets a ceiling; a made-to-order listing sets a floor, because a vendor will not start a run below its batch minimum, and the minimum order quantity tiers on that page describe production economics more accurately than the stock badge does.